My cart
In the shopping cart is not goods, to choose and buy!
  • Product Name
  • Size
  • Quantity
  • Amount
    Selected items : 0 pieces Total : CHECK OUT()
    Catalog No: V0583
    CAS No. (CAS Registry Number): 841290-81-1
    Description: Tamatinib besylate (formerly R-406 besylate; prodrug of R 406) is a novel, potent and ATP-competitive inhibitor of spleen tyrosine kinase/Syk with potential anti-inflammato...
    Catalog No: V0584
    CAS No. (CAS Registry Number): 950769-58-1
    Description: Quizartinib (formerly also know as AC-220; AC-010220, brand name Vanflyta in Japan) is a novel, potent, 2nd-generation, and orally bioavailable FLT3 tyrosine kinase inhibitor for Flt...
    Catalog No: V0585
    CAS No. (CAS Registry Number): 387867-13-2
    Description: Tandutinib (formerly also known as MLN-518, CT-53518, D06005, NSC726292), a piperazinyl quinazoline, is a novel, potent and selective FLT3 inhibitor/antagonist with potential antitum...
    Catalog No: V0586
    CAS No. (CAS Registry Number): 2070015-17-5
    Description: UNC-2025 HCl (known also as UNC2025), the Hydrochloride salt of UNC-2025, is an orally bioavailable and selective MER/FLT3 dual inhibitor with potential antineoplastic acti...
    Catalog No: V0587
    CAS No. (CAS Registry Number): 1401033-86-0
    Description: AMG 925 (also called FLX-925; AMG-925) is a novel, potent, selective and orally bioavailable FLT3/CDK4 dual inhibitor with potential antitumor activity. It inhibits FLT3/CDK4 wi...
    Catalog No: V0588
    CAS No. (CAS Registry Number): 1457983-28-6
    Description: G-749 (G749) is a novel and potent FLT3 inhibitor with potential antineoplastic activity. It inhibits FLT3 (WT), FLT3 (D835Y), and Mer with IC50s of 0.4 nM, 0.6 nM and 1 nM, respectively....
    8页次1/2首页<12>尾页
    Products are for research use only;  We do not sell to patients
    Tel: 1-708-310-1919
    Fax: 1-708-557-7486
    Subscribe to our E-newsletter
    • Name*
    • *
    • E-mail*
    • *
    • instructions:
    • *
    Copyright 2020 InvivoChem LLC | All Rights Reserved